Stocks and Investing
Stocks and Investing
Wed, April 29, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 28, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $210 on, Apr 28th, 2020
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $200 to $210 on, Apr 28th, 2020.
Raghuram has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Joseph Thome of "Cowen & Co." Initiated at Buy and Held Target at $95 on, Tuesday, April 14th, 2020